Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Prostaglandins Leukot Essent Fatty Acids. 2020 Sep 19;162:102180. doi: 10.1016/j.plefa.2020.102180

Figure 2.

Figure 2.

sEH is a novel endogenous regulator of obesity-induced intestinal barrier dysfunction. Genetic ablation or inhibition of sEH could attenuate various obesity-induced disorders, through inhibiting obesity-induced intestinal barrier dysfunction.